MedPath

Exploratory study of severity index for COVID-19 patients

Not Applicable
Conditions
ovel Coronavirus Infectious Disease (COVID-19)
COVID-19 pneumonia
C000657245
Registration Number
JPRN-jRCT1052200041
Lead Sponsor
sawa Yoshiki
Brief Summary

When we obtained the Respiratory stability Time (RST) of COVID-19 patients and pneumonia patients with a body motion sensor and analyzed the relationship between RST and clinical symptoms, we found that Moderate II or Severe patients have lower RST than Mild or Moderate I patients. It was suggested that RST increased when the symptoms of COVID-19 improved, and that RST decreased when COVID-19 worsened.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

1)20 years old or older at informed consent
2)SARS-CoV-2 positive or pneumonia
3)Patients who have given written consent to participate

Exclusion Criteria

1)Patients who are considered inappropriate for inclusion in the study by the investigator

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath